Skip to main content
Caplight Logo









Zanoprima Lifesciences

Zanoprima Lifesciences

Private
LondonHealthcare & Life Scienceshttps://zanoprima.com

Company Overview

Zanoprima Lifesciences operates in Healthcare & Life Sciences and is based in London. It was founded in 2014.

Zanoprima Lifesciences is a life sciences company that manufactures high-purity synthetic (S)-nicotine for use in nicotine replacement therapies and next-generation nicotine products.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Pharma Supply Chain, Clean Manufacturing, Compliance

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Zanoprima Lifesciences Comparables

Compare Zanoprima Lifesciences with similar companies based on industry and business-model similarity.

Zanoprima Lifesciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Next Generation Labs
89%
Chemnovatic
82%
eLiquiTech
82%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Zanoprima Lifesciences Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for Zanoprima Lifesciences. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Anand Ashok

Chief Executive Officer

Executive Team

Phani Kumar Ganapavarapu

Group CFO

Executive Team

For institutional investors. Book with your work email.

Zanoprima Lifesciences Investors

Notable investors and investment history

Zanoprima Lifesciences investors
InvestorRounds
ASPIRE-BioNESTAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 17, 2026

    Monthly visitors increased 54% MoM, reaching 1.6K.

  • Nov 10, 2025

    Monthly visitors grew 226% MoM, reaching 2.2K.

Book a demo to see all signals

For institutional investors. Book with your work email.

Zanoprima Lifesciences Filings

Explore SEC and related filing metadata, where available.

Zanoprima Lifesciences filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Zanoprima Lifesciences's valuation, stock price, and market status.

Is Zanoprima Lifesciences a public or private company?

Zanoprima Lifesciences is a private company.

What is the current stock price of Zanoprima Lifesciences?

Zanoprima Lifesciences is a private company, so its shares have no public market price. Caplight tracks Zanoprima Lifesciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Zanoprima Lifesciences worth (valuation)?

Valuation information for Zanoprima Lifesciences is not publicly available.

Can I buy Zanoprima Lifesciences stock?

Zanoprima Lifesciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Zanoprima Lifesciences's last funding round?

Funding round information for Zanoprima Lifesciences is not publicly available.

Who are the main investors in Zanoprima Lifesciences?

Key investors in Zanoprima Lifesciences include ASPIRE-BioNEST.

Will Zanoprima Lifesciences IPO soon?

No public IPO plans have been announced for Zanoprima Lifesciences.

How can I track Zanoprima Lifesciences secondary market activity?

Caplight tracks bids, offers, and trades in Zanoprima Lifesciences's shares on secondary markets.

Firmographic Details

HeadquartersLondon
Employee Range5
Year Founded2014
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?